Image Sensor Market Size, Industry Growth at a CAGR of 8.1%
May 08, 2024 21:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 08, 2024 (GLOBE NEWSWIRE) -- The Image Sensor Market size is projected to reach USD 38.6 billion by 2027 from an estimated USD 26.1 billion in 2022, at a CAGR of 8.1% from 2022 to 2027....
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
May 08, 2024 21:15 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
Volaris Celebrates Frontier Airlines’ Reactivation of the Codeshare Agreement Between Both Airlines
May 08, 2024 21:09 ET
|
Controladora Vuela Compañía de Aviación, S.A.B. de C.V.
MEXICO CITY, May 08, 2024 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC)...
Listing of Exodus Class A Common Stock Delayed by NYSE American
May 08, 2024 21:05 ET
|
Exodus
OMAHA, Neb., May 08, 2024 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (OTCQX: EXOD) (the “Company” or “Exodus”) today announced that it was informed by the NYSE American that the exchange has delayed...
Novotech, 이상지질혈증과 비소세포폐암 관련 글로벌 임상시험 환경 보고서 발표
May 08, 2024 21:03 ET
|
Novotech
보스턴, May 09, 2024 (GLOBE NEWSWIRE) -- 바이오테크 업체들과의 파트너십에 기반해 임상시험 모든 단계의 첨단 및 신규 치료제 개발 가속화에 주력하는 글로벌 풀서비스 임상시험수탁기관(CRO)인 노보텍(Novotech)이 이상지질혈증과 비소세포폐암(NSCLC)을 주제로 한 2023년도 최신판 글로벌 임상시험 환경 보고서를 발표했다....
Novotech 發布有關血脂異常和非小細胞肺癌全球臨床試驗概況的新報告
May 08, 2024 21:03 ET
|
Novotech
波士頓, May 09, 2024 (GLOBE NEWSWIRE) -- Novotech，一家以亞太地區為中心、具有全球執行能力的領先生物技術臨床合同研究組織 (CRO) 於今日發布了關於血脂異常和非小細胞肺癌 (NSCLC) 的最新 2023 年全球臨床試驗情況報告。 Novotech...
Novotech 发布有关血脂异常和非小细胞肺癌全球临床试验概况的新报告
May 08, 2024 21:03 ET
|
Novotech
波士顿, May 09, 2024 (GLOBE NEWSWIRE) -- Novotech，一家以亚太地区为中心、具有全球执行能力的领先生物技术临床合同研究组织 (CRO) 于今日发布了关于血脂异常和非小细胞肺癌 (NSCLC) 的最新 2023 年全球临床试验情况报告。 Novotech...
Novotech 發布精準腫瘤學白皮書，確定靶向治療的當前趨勢和機遇
May 08, 2024 21:03 ET
|
Novotech
波士頓, May 09, 2024 (GLOBE NEWSWIRE) -- Novotech 是一家提供全方位服務的全球性臨床合同研究組織 (CRO)，其與生物技術公司開展合作，從而在各階段加速開發先進的新型療法。Novotech 發布了一份富有洞察力的白皮書，精準腫瘤學 - 全球臨床試驗格局，提供了癌症治療的最新研究見解。 Novotech...
Novotech 发布精准肿瘤学格局白皮书，指出靶向治疗的当前趋势和机遇
May 08, 2024 21:03 ET
|
Novotech
波士顿, May 09, 2024 (GLOBE NEWSWIRE) -- Novotech 是一家提供全方位服务的全球性临床合同研究组织 (CRO)，它与生物技术公司合作，加速各个阶段先进和新颖疗法的开发。其最近发布了一份颇具见地的白皮书，《精准肿瘤学：全球临床试验格局》，为癌症治疗提供最新的研究见解。 Novotech...
VESTIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Vestis Corporation on Behalf of Vestis Stockholders and Encourages Investors to Contact the Firm
May 08, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Vestis Corporation...